| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/03/2003 | WO2002012447B1 Isolation and use of solid tumor stem cells |
| 07/03/2003 | WO2002010452A3 Methods and compositions for predicting prostate cancer |
| 07/03/2003 | WO2002010436A3 Prognostic classification of breast cancer |
| 07/03/2003 | WO2002000938A9 Methods and compositions for transcription-based nucleic acid amplification |
| 07/03/2003 | WO2001077392B1 Methods for the survey and genetic analysis of populations |
| 07/03/2003 | WO2000074667A3 Compositions active in telomere damage comprising a taxane and telomerase inhibitor |
| 07/03/2003 | WO2000031303A3 Methods for stool sample preparation |
| 07/03/2003 | US20030126645 Expression vectors for modifying oil and size phenotypes; genetic mapping variation in crop plants |
| 07/03/2003 | US20030126636 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 07/03/2003 | US20030126630 Plant sterol reductases and uses thereof |
| 07/03/2003 | US20030125882 Method and apparatus for providing a bioinformatics database |
| 07/03/2003 | US20030125562 Functionalized 4-imino-3-mercapto-1,2,4-triazoles as inhibitors of nitric oxide synthase (NOS) and as inhibitors of malignant cell growth |
| 07/03/2003 | US20030125542 Magnetic particles for purifying nucleic acids |
| 07/03/2003 | US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines |
| 07/03/2003 | US20030125534 Nucleotide sequences coding hydrolases for use in cleaning agents, detergents, textile treatment, baking, inking recycled paper, animal feeds, beverages and in the oilfield industry |
| 07/03/2003 | US20030125533 Regulation of human sphingosine kinase-like protein |
| 07/03/2003 | US20030125523 Novel neuropilin/growth factor complexes and uses thereof |
| 07/03/2003 | US20030125403 Comprises cellulose acetates as polymer, 1,4-dioxane, 4-hydroxymethylpentanone, and/or ethyl acetate as solvent, and n-octanol and/or 2-methyl-2,4-pentanediol as pore former; for measuring blood glucose concentration/hematocrit |
| 07/03/2003 | US20030125337 Enhancing the antibacterial action of fluoroquinolones by contacting a bacterium with an indole, a urea, an aromatic amide or a quinoline |
| 07/03/2003 | US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease |
| 07/03/2003 | US20030125289 Noonan syndrome gene |
| 07/03/2003 | US20030125286 Transcriptional silencer protein NRF |
| 07/03/2003 | US20030125285 Method of examining efficacy of therapy with nucleic acid |
| 07/03/2003 | US20030125284 Agents that modulate DNA-PK activity and methods of use thereof |
| 07/03/2003 | US20030125282 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER) |
| 07/03/2003 | US20030125275 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 07/03/2003 | US20030125269 T-type calcium channel |
| 07/03/2003 | US20030125265 Administering to a cancer paient a compound (emodin, genistein) having anti-estrogen receptor activity and tyrosine kinase inhibitor activity to prevent esterogen receptor positive cancer cells |
| 07/03/2003 | US20030125263 Nucleic acid ligand complexes |
| 07/03/2003 | US20030125258 Bone polypeptide-1 |
| 07/03/2003 | US20030125257 A olilgopeptide or polypeptide containing Leustatin, Chastatin or Tyrstatin |
| 07/03/2003 | US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems |
| 07/03/2003 | US20030125246 Respiratory system related polynucleotides and the polypeptides encoded by these polynucleotides known as respiratory system antigens useful for detecting cancer or cancer metastases of respiratory system tissues |
| 07/03/2003 | US20030125245 Compositions and methods for therapy and diagnosis of lung cancer |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030125233 Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling |
| 07/03/2003 | US20030125231 Identification of agents useful in the treatment of such diseases based upon the agent's effect on reducing Pim-2 expression. Polypeptides and genetic engineering |
| 07/03/2003 | US20030124746 Light-controlled electrokinetic assembly of particles near surfaces |
| 07/03/2003 | US20030124716 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 07/03/2003 | US20030124706 Proteases |
| 07/03/2003 | US20030124695 Genes encoding baeyer-villiger monooxygenases |
| 07/03/2003 | US20030124689 Mitomycin biosynthetic gene cluster |
| 07/03/2003 | US20030124662 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030124655 Receptor protein specifically recognizing bacterial dna |
| 07/03/2003 | US20030124654 Method and device for the rapid clinical diagnosis of hepatitis C virus (HCV) infection in biological samples |
| 07/03/2003 | US20030124651 Hybridizing amplified HBV nucleic acids with an oligonucleotide probe in the presence of an enzyme that cleaves said probe |
| 07/03/2003 | US20030124649 Membrane associated proteins |
| 07/03/2003 | US20030124643 Method and kit forrapid concurrent identification and antimicrobial susceptibility testing of microorganisms from broth culture |
| 07/03/2003 | US20030124642 Inhibition of 5-Aminolevulinate synthase gene expression in fungi results in no signs of successful infection or lesions. 5-Aminolevulinate synthase can be used as a target for the identification of antibiotics, preferably antifungals. |
| 07/03/2003 | US20030124641 Method for identifying endocrine disruptors and kit for carrying out the same |
| 07/03/2003 | US20030124640 Evaluating success of in vitro fertilization; 11 beta hydroxysteroid dehydrogenases (bhd); contraceptives; glycyrrhetinic acid-like factor (GALF) |
| 07/03/2003 | US20030124639 Bioanalytical measuring method for determining catalases and peroxidases, as well as conjugates, substrates, activators and inhibitors thereof |
| 07/03/2003 | US20030124638 Low molecular weight heparin assay, system and reagent therefor |
| 07/03/2003 | US20030124636 Monitoring metabolic phenotypes of bradycardial agents; immunoassays |
| 07/03/2003 | US20030124629 Methods of detecting a cell |
| 07/03/2003 | US20030124622 Procedure for the determination of the activity of the protease which activates factor VII from protein solutions |
| 07/03/2003 | US20030124611 Elongated and fixed onto a planar surface so they remain accessible for enzymatic and/or hybridization reactions |
| 07/03/2003 | US20030124609 Ankyrin repeat domain 2 protein variant |
| 07/03/2003 | US20030124608 Polymorphisms detected by hybridization of oligonucleotides with a nucleic acid derived from the fish |
| 07/03/2003 | US20030124605 Determining a DNA lesion in a eukaryotic cell; use in diagnosis of diseases |
| 07/03/2003 | US20030124604 Method for amplification of molecular bio-assay signals |
| 07/03/2003 | US20030124602 Tumour suppresor and uses thereof |
| 07/03/2003 | US20030124600 Determining methylation ratio of a promoter region of glutathione-S-transferase relative to the level in a reference gene; polymerase chain reaction |
| 07/03/2003 | US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 07/03/2003 | US20030124597 Compositions and methods for identifying agents which regulate autolytic processes in bacteria |
| 07/03/2003 | US20030124596 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 07/03/2003 | US20030124595 Sensitive coded detection systems |
| 07/03/2003 | US20030124594 Immobilized spots with binding activity; improve efficiency of polymerase chain reaction |
| 07/03/2003 | US20030124593 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/03/2003 | US20030124592 Identifying a nucleic acid molecule or gene by hybridizing with a primer; detecting change in a parameter |
| 07/03/2003 | US20030124591 Gene used in diagnosis and treatment |
| 07/03/2003 | US20030124590 Carbohydrate response element binding protein and uses thereof |
| 07/03/2003 | US20030124588 Methods for controlling cross-hybridization in analysis of nucleic acid sequences |
| 07/03/2003 | US20030124587 Human tyrosine-DNA phosphodiesterase variant polypeptides and methods of use therefor |
| 07/03/2003 | US20030124586 In vitro sorting method |
| 07/03/2003 | US20030124584 Methods for detecting genetic mosaicisms using arrays |
| 07/03/2003 | US20030124583 Solid matrix carrier; surface is subdivided for binding different analytes; use in diagnostics |
| 07/03/2003 | US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 07/03/2003 | US20030124581 Newborn screening for hemoglobinopathy by DNA microarray analysis |
| 07/03/2003 | US20030124579 Contacting nucleic acids from a patient with a polynucleotide; hybridization; expression vectors |
| 07/03/2003 | US20030124578 Assay for detection of human parvovirus B19 nucleic acid |
| 07/03/2003 | US20030124577 Diagnosing ataxia telangiectasia (AT) and breast cancer; kinases |
| 07/03/2003 | US20030124576 Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases |
| 07/03/2003 | US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening |
| 07/03/2003 | US20030124572 Assay electrode having immobilized lipid/protein layers, methods of making the same and methods of using the same for luminescence test measurements |
| 07/03/2003 | US20030124570 Methods for screening for proteins comprising a signal sequence |
| 07/03/2003 | US20030124566 5-Hydroxytryptamine transporter gene polymorphisms |
| 07/03/2003 | US20030124564 DNA sequence determination; 3-mercaptopropyl trimethoxysilane microarrays; fluorometry; solid phase synthesis |
| 07/03/2003 | US20030124563 Immunohistochemistry; tumor diagnosis; antitumor agents; anticarcinogenic agents; tissue engineering; ki-67 proteins |
| 07/03/2003 | US20030124561 Plant centromere compositions |
| 07/03/2003 | US20030124560 Method for analyzing a target nucleic acid fragment and a kit for analyzing a target nucleic acid fragment |
| 07/03/2003 | US20030124559 Rna polymerases from bacteriophage phi 6-phI 14 and use thereof |
| 07/03/2003 | US20030124558 Monitoring gestation in humans; in vitro fertilization and embryo transfer; progestins; immunohistochemistry |
| 07/03/2003 | US20030124556 Detecting bacteria or viral nucleotide sequences; restriction fragment length polymorphism; fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS); ion trap; time of flight |
| 07/03/2003 | US20030124555 Compositions and methods for use in isolation of nucleic acid molecules |
| 07/03/2003 | US20030124554 Screening method for compounds capable of modularing egr-1-regulated expression |
| 07/03/2003 | US20030124553 Skin treatment |
| 07/03/2003 | US20030124552 Biochips and method of screening using drug induced gene and protein expression profiling |
| 07/03/2003 | US20030124551 Agents implicated in endometriosis |
| 07/03/2003 | US20030124548 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |